227 related articles for article (PubMed ID: 34943983)
1. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.
Danek PJ; Daniel WA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943983
[No Abstract] [Full Text] [Related]
2. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects.
Danek PJ; Bromek E; Haduch A; Daniel WA
Neurochem Int; 2021 Dec; 151():105209. PubMed ID: 34666077
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms.
Danek PJ; Kuban W; Daniel WA
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445153
[TBL] [Abstract][Full Text] [Related]
5. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.
Haduch A; Bromek E; Daniel WA
Eur J Pharmacol; 2011 Jan; 651(1-3):51-8. PubMed ID: 21115002
[TBL] [Abstract][Full Text] [Related]
6. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
Danek PJ; Wójcikowski J; Daniel WA
Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
Szczepanik AM; Brougham LR; Roehr JE; Conway PG; Ellis DB; Wilmot CA
J Pharmacol Exp Ther; 1996 Aug; 278(2):913-20. PubMed ID: 8768747
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats.
Haduch A; Danek PJ; Kuban W; Pukło R; Alenina N; Gołębiowska J; Popik P; Bader M; Daniel WA
Neurochem Int; 2022 Jan; 152():105223. PubMed ID: 34780807
[TBL] [Abstract][Full Text] [Related]
9. The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain.
Haduch A; Bromek E; Pukło R; Jastrzębska J; Danek PJ; Daniel WA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430225
[TBL] [Abstract][Full Text] [Related]
10. Expression and localisation of CYP2D enzymes in rat basal ganglia.
Riedl AG; Watts PM; Edwards RJ; Schulz-Utermoehl T; Boobis AR; Jenner P; Marsden CD
Brain Res; 1999 Mar; 822(1-2):175-91. PubMed ID: 10082895
[TBL] [Abstract][Full Text] [Related]
11. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.
Bromek E; Haduch A; Daniel WA
Eur J Pharmacol; 2010 Jan; 626(2-3):171-8. PubMed ID: 19818757
[TBL] [Abstract][Full Text] [Related]
12. The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
Szewczak MR; Corbett R; Rush DK; Wilmot CA; Conway PG; Strupczewski JT; Cornfeldt M
J Pharmacol Exp Ther; 1995 Sep; 274(3):1404-13. PubMed ID: 7562515
[TBL] [Abstract][Full Text] [Related]
13. Iloperidone: A new drug for the treatment of schizophrenia.
Arif SA; Mitchell MM
Am J Health Syst Pharm; 2011 Feb; 68(4):301-8. PubMed ID: 21289324
[TBL] [Abstract][Full Text] [Related]
14. New atypical antipsychotics for schizophrenia: iloperidone.
Caccia S; Pasina L; Nobili A
Drug Des Devel Ther; 2010 Feb; 4():33-48. PubMed ID: 20368905
[TBL] [Abstract][Full Text] [Related]
15. Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy.
Danek PJ; Wójcikowski J; Daniel WA
Toxicol Appl Pharmacol; 2020 Nov; 406():115239. PubMed ID: 32941854
[TBL] [Abstract][Full Text] [Related]
16. The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat.
Haduch A; Rysz M; Papp M; Daniel WA
Biochem Pharmacol; 2018 Oct; 156():398-405. PubMed ID: 30195732
[TBL] [Abstract][Full Text] [Related]
17. Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion.
Citrome L
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1551-64. PubMed ID: 21034370
[TBL] [Abstract][Full Text] [Related]
18. The effect of ageing and cerebral serotonin deficit on the activity of cytochrome P450 2D (CYP2D) in the brain and liver of male rats.
Haduch A; Pukło R; Alenina N; Nikiforuk A; Popik P; Bader M; Daniel WA
Neurochem Int; 2020 Dec; 141():104884. PubMed ID: 33091481
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Effects of Iloperidone on Cerebral Serotonin and Adrenoceptor Subtypes.
Choi YK; Tarazi FI
J Mol Neurosci; 2018 Sep; 66(1):59-67. PubMed ID: 30091081
[TBL] [Abstract][Full Text] [Related]
20. An assessment of iloperidone for the treatment of schizophrenia.
Jain KK
Expert Opin Investig Drugs; 2000 Dec; 9(12):2935-43. PubMed ID: 11093363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
